- Trials with a EudraCT protocol (128)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
128 result(s) found for: Fluorescein angiography.
Displaying page 1 of 7.
EudraCT Number: 2009-012509-20 | Sponsor Protocol Number: MERLOT | Start Date*: 2009-07-28 | |||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | |||||||||||||
Full Title: A randomised controlled trial of epimacular brachytherapy versus ranibizumab monotherapy for the treatment of subfoveal choroidal neovascularisation associated with wet age-related macular degenera... | |||||||||||||
Medical condition: Wet age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003923-31 | Sponsor Protocol Number: OPH2007 | Start Date*: 2018-01-30 | |||||||||||
Sponsor Name:OPHTHOTECH CORPORATION | |||||||||||||
Full Title: A Phase 2A Open-Label Trial to Assess the Safety of Zimura™ (Anti-C5) Administered in Combination With Lucentis® 0.5 mg in Treatment Naïve Subjects with Neovascular Age Related Macular Degeneration | |||||||||||||
Medical condition: Neovascular Age Related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005157-33 | Sponsor Protocol Number: 1 | Start Date*: 2008-05-14 |
Sponsor Name:Ludwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie | ||
Full Title: A randomized observer and subject masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration Multicenter... | ||
Medical condition: Subjects of either gender, aged> 50 years, presenting with subfoveal choroidal neovascularization due to age-related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006290-90 | Sponsor Protocol Number: AU-06102G | Start Date*: 2008-10-10 | |||||||||||
Sponsor Name:Society (Institute) for clinical research | |||||||||||||
Full Title: Subretinal Macugen for neovascular age-related macular degeneration (SUMANA) | |||||||||||||
Medical condition: Neovascular (exudative) age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002977-33 | Sponsor Protocol Number: Luc01AKSI | Start Date*: 2006-06-22 |
Sponsor Name:University Eye Hospital | ||
Full Title: Safety and efficacy of intravitreal injections of ranibizumab/Lucentis in combination with verteporfin photodynamic therapy (PDT) in patients with choroidal neovascularisation (CNV) secondary to ag... | ||
Medical condition: Age related macular degeneration (AMD) is the leading cause of blindness in individuals older than 50 years in the developed world. Eighty to ninety percent of rapid and severe vision loss due to A... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003288-21 | Sponsor Protocol Number: EURIVAT2 | Start Date*: 2005-09-28 |
Sponsor Name:Dept. of Ophthalmology, Medical University of Vienna | ||
Full Title: INTRAOCULAR BEVACIZUMAB (AVASTIN™) FOR CENTRAL AND BRANCH RETINAL VEIN OCCLUSION STUDY | ||
Medical condition: CENTRAL AND BRANCH RETINAL VEIN OCCLUSION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001235-30 | Sponsor Protocol Number: MSI-1256F-302 | Start Date*: 2005-10-26 |
Sponsor Name:Genaera Corporation | ||
Full Title: A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated with Age-Re... | ||
Medical condition: Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003653-16 | Sponsor Protocol Number: S62092 | Start Date*: 2019-03-21 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Abatacept in patients with Birdshot HLA A29 uveitis: A Phase II Prospective 0pen Label Interventional Proof-of-Concept Study | |||||||||||||
Medical condition: Birdshot Uveitis HLA A29 retinochoroiditis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004567-30 | Sponsor Protocol Number: 1313.20 | Start Date*: 2014-04-15 | |||||||||||
Sponsor Name:Boehringer Ingelheim RCV GmbH & Co KG | |||||||||||||
Full Title: A single arm open label study to evaluate the pharmacodynamics and safety of a 4 wk treatment with BI 144807 in patients with newly diagnosed wet age related macular degeneration (wAMD) | |||||||||||||
Medical condition: patients with newly diagnosed, unilateral, wet Are-Related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002626-23 | Sponsor Protocol Number: CRFB002A2411 | Start Date*: 2013-11-26 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: A 12-month, phase IIIb, randomized, visual acuity, assessor-masked, multicenter study assessing the efficacy and safety of ranibizumab 0.5mg in treat and extend regimen compared to monthly regimen,... | |||||||||||||
Medical condition: Visual impairment due to neovascular AMD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) BE (Completed) DE (Completed) SK (Completed) GB (Completed) HU (Completed) PT (Completed) DK (Completed) SI (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000848-26 | Sponsor Protocol Number: BMF-AFLI-2013-01 | Start Date*: 2013-07-04 |
Sponsor Name:Barcelona Macula Foundation | ||
Full Title: Phase IV study to evaluate the efficacy of aflibercept in subjects with neovascular age-related macular degeneration (wAMD), without optimal response to repeated monthly intravitreal injections of ... | ||
Medical condition: Wet age-related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005464-14 | Sponsor Protocol Number: LucNVG0108 | Start Date*: 2009-03-30 | ||||||||||||||||
Sponsor Name:Prof. Salvatore Grisanti | ||||||||||||||||||
Full Title: An open label, prospective, monocenter, prove of concept study to evaluate the short- and long-term effects of 0.5mg intraocular Ranibizumab (Lucentis) injections as adjuvant for patients with rube... | ||||||||||||||||||
Medical condition: Rubeosis and Neovascular Glaucoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007476-19 | Sponsor Protocol Number: OP/2008/2980 | Start Date*: 2009-09-24 |
Sponsor Name:University Hospitals Bristol NHS Trust | ||
Full Title: A prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes. | ||
Medical condition: idiopathic and inflammatory choroidal neovascular membranes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001678-25 | Sponsor Protocol Number: 138/06 | Start Date*: 2006-02-16 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Macular structure and function after intravitreal injection of bevacizumab for vascular retinopathy a interventional study. | |||||||||||||
Medical condition: vascular retinopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016158-42 | Sponsor Protocol Number: IT-04-1-8-09 | Start Date*: 2009-12-23 | |||||||||||
Sponsor Name:U.L.S.S. 16 | |||||||||||||
Full Title: Efficacy of intravitreal bevacizumab for exudative age-related macular degeneration. | |||||||||||||
Medical condition: Exudative age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001492-37 | Sponsor Protocol Number: Z-AMD | Start Date*: 2019-11-01 | |||||||||||
Sponsor Name:Oslo University Hospital | |||||||||||||
Full Title: Zoledronic acid as adjuvant therapy in neovascular Age-related Macular Degeneration (The Z-AMD study): a randomized controlled pilot study | |||||||||||||
Medical condition: Neovascular Age-related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001171-36 | Sponsor Protocol Number: TG-MV-001 | Start Date*: 2005-05-13 |
Sponsor Name:ThromboGenics Ltd. | ||
Full Title: A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy | ||
Medical condition: Vitreomacular Traction Maculopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-005043-97 | Sponsor Protocol Number: 04/MA/003E | Start Date*: 2005-06-30 |
Sponsor Name:St Mary's NHS Trust | ||
Full Title: A Pilot study investigating the use of Intravitreal Triamcinolone prior to macular laser for Clinically Significant Diabetic Macular Oedema | ||
Medical condition: Macular oedema affects 29% of diabetic patients and is the main cause of visual impairment. Previous studies show that diffuse macular oedema carries a particularly poor prognosis despite laser pho... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002466-11 | Sponsor Protocol Number: version125/05/05 | Start Date*: 2006-01-03 |
Sponsor Name:King's College Hospital | ||
Full Title: A Pilot Study to Examine the Safety and Efficacy of Posterior Juxtascleral Triamcinolone acetonide administration, in addition to Visudyne photoynamic therapy for predominantly Classic Choroidal N... | ||
Medical condition: Classic or predominantly classic age related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005450-71 | Sponsor Protocol Number: LUZVT06 | Start Date*: 2007-06-29 |
Sponsor Name:Augenklinik der LMU München | ||
Full Title: INTRAVITREAL RANIBIZUMAB THERAPY FOR MACULA EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION (RAVO) | ||
Medical condition: Macula edema resulting from central retinal vein occlusion in the eye | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
